1、Flitcroft DI, He M, Jonas JB, et al. IMI - defining and classifying
myopia: a proposed set of standards for clinical and epidemiologic studies[ J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M20-M30.Flitcroft DI, He M, Jonas JB, et al. IMI - defining and classifying
myopia: a proposed set of standards for clinical and epidemiologic studies[ J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M20-M30.
2、Naidoo KS, Fricke TR, Frick KD, et al. Potential lost productivity
resulting from the global burden of myopia: systematic review, meta-analysis, and modeling[ J]. Ophthalmology, 2019, 126(3): 338-346.Naidoo KS, Fricke TR, Frick KD, et al. Potential lost productivity
resulting from the global burden of myopia: systematic review, meta-analysis, and modeling[ J]. Ophthalmology, 2019, 126(3): 338-346.
3、Bullimore MA, Ritchey ER, Shah S, et al. The risks and benefits of
myopia control[ J]. Ophthalmology, 2021, 128(11): 1561-1579.Bullimore MA, Ritchey ER, Shah S, et al. The risks and benefits of
myopia control[ J]. Ophthalmology, 2021, 128(11): 1561-1579.
4、Zhu Z, Ellwein LB, Wang SK, et al. Meeting the need for corrective
spectacles in visually impaired Chinese school children: the potential of
ready-made spectacles[ J]. Br J Ophthalmol, 2019, 103(8): 1106-1111.Zhu Z, Ellwein LB, Wang SK, et al. Meeting the need for corrective
spectacles in visually impaired Chinese school children: the potential of
ready-made spectacles[ J]. Br J Ophthalmol, 2019, 103(8): 1106-1111.
5、兰蓝, 周婷, 孟琼, 等. 国外疾病经济负担研究现状分析[ J]. 预防
医学情报杂志, 2018, 34(1): 106-109.
Lan L, Zhou T, Meng Q, et al. Situation of abroad research on economic
burden of diseases[ J]. J Prev Med Inf, 2018, 34(1): 106-109.兰蓝, 周婷, 孟琼, 等. 国外疾病经济负担研究现状分析[ J]. 预防
医学情报杂志, 2018, 34(1): 106-109.
Lan L, Zhou T, Meng Q, et al. Situation of abroad research on economic
burden of diseases[ J]. J Prev Med Inf, 2018, 34(1): 106-109.
6、侯儒寅, 高凤清. 疾病经济负担研究方法案例分析[ J]. 中国医药
导报, 2012, 9(3): 146-147.
Hou RY, Gao FQ. Case analysis of research methods for economic
burden of disease[ J]. China Med Her, 2012, 9(3): 146-147.侯儒寅, 高凤清. 疾病经济负担研究方法案例分析[ J]. 中国医药
导报, 2012, 9(3): 146-147.
Hou RY, Gao FQ. Case analysis of research methods for economic
burden of disease[ J]. China Med Her, 2012, 9(3): 146-147.
7、Foo LL, Lanca C, Wong CW, et al. Cost of myopia correction: a
systematic review[ J]. Front Med, 2021, 8: 718724.Foo LL, Lanca C, Wong CW, et al. Cost of myopia correction: a
systematic review[ J]. Front Med, 2021, 8: 718724.
8、Lim MCC, Gazzard G, Sim EL, et al. Direct costs of myopia in
Singapore[ J]. Eye, 2009, 23(5): 1086-1089.Lim MCC, Gazzard G, Sim EL, et al. Direct costs of myopia in
Singapore[ J]. Eye, 2009, 23(5): 1086-1089.
9、Ma Y, Wen Y, Zhong H, et al. Healthcare utilization and economic
burden of myopia in urban China: a nationwide cost-of-illness study[ J].
J Glob Health, 2022, 12: 11003.Ma Y, Wen Y, Zhong H, et al. Healthcare utilization and economic
burden of myopia in urban China: a nationwide cost-of-illness study[ J].
J Glob Health, 2022, 12: 11003.
10、Zheng YF, Pan CW, Chay J, et al. The economic cost of myopia in adults
aged over 40 years in Singapore[ J]. Invest Ophthalmol Vis Sci, 2013,
54(12): 7532-7537.Zheng YF, Pan CW, Chay J, et al. The economic cost of myopia in adults
aged over 40 years in Singapore[ J]. Invest Ophthalmol Vis Sci, 2013,
54(12): 7532-7537.
11、Wittenborn JS, Zhang X, Feagan CW, et al. The economic burden
of vision loss and eye disorders among the United States population
younger than 40 years[ J]. Ophthalmology, 2013, 120(9): 1728-1735.Wittenborn JS, Zhang X, Feagan CW, et al. The economic burden
of vision loss and eye disorders among the United States population
younger than 40 years[ J]. Ophthalmology, 2013, 120(9): 1728-1735.
12、方翔, 刘玺. HIS系统在疾病直接经济负担测算中的应用[ J]. 福
建电脑, 2016, 32(12): 13-14.
Fang X, Liu X. Application of HIS system in the calculation of direct
economic burden of disease[ J]. Fujian Comput, 2016, 32(12): 13-14.方翔, 刘玺. HIS系统在疾病直接经济负担测算中的应用[ J]. 福
建电脑, 2016, 32(12): 13-14.
Fang X, Liu X. Application of HIS system in the calculation of direct
economic burden of disease[ J]. Fujian Comput, 2016, 32(12): 13-14.
13、Fricke TR, Sankaridurg P, Naduvilath T, et al. Establishing a method to
estimate the effect of antimyopia management options on lifetime cost
of myopia[ J]. Br J Ophthalmol, 2023, 107(8): 1043-1050.Fricke TR, Sankaridurg P, Naduvilath T, et al. Establishing a method to
estimate the effect of antimyopia management options on lifetime cost
of myopia[ J]. Br J Ophthalmol, 2023, 107(8): 1043-1050.
14、Ruiz-Moreno JM, Roura M, del grupo del estudio Mypathway
ER . Cost of myopic patients with and without myopic choroidal
neovascularisation[ J]. Arch Soc Esp Oftalmol, 2016, 91(6): 265-272.Ruiz-Moreno JM, Roura M, del grupo del estudio Mypathway
ER . Cost of myopic patients with and without myopic choroidal
neovascularisation[ J]. Arch Soc Esp Oftalmol, 2016, 91(6): 265-272.
15、Mohammadi SF, Alinia C, Tavakkoli M, et al. Refractive surgery: the
most cost-saving technique in refractive errors correction[ J]. Int J
Ophthalmol, 2018, 11(6): 1013-1019.Mohammadi SF, Alinia C, Tavakkoli M, et al. Refractive surgery: the
most cost-saving technique in refractive errors correction[ J]. Int J
Ophthalmol, 2018, 11(6): 1013-1019.
16、宋子伟, 张梅, 王志会, 等. 大数据背景下的脑卒中疾病负担研究
方法概述[ J]. 中华流行病学杂志, 2021, 42(9): 1695-1699.
Song ZW, Zhang M, Wang ZH, et al. Summary of research methods
of stroke disease burden in big data era[ J]. Chin J Epidemiol, 2021,
42(9): 1695-1699.宋子伟, 张梅, 王志会, 等. 大数据背景下的脑卒中疾病负担研究
方法概述[ J]. 中华流行病学杂志, 2021, 42(9): 1695-1699.
Song ZW, Zhang M, Wang ZH, et al. Summary of research methods
of stroke disease burden in big data era[ J]. Chin J Epidemiol, 2021,
42(9): 1695-1699.
17、Ivanova-Markova Y, González-Domínguez A, Hidalgo A, et al. Cost
of illness of invasive meningococcal disease caused by serogroup B
Neisseria meningitidis in Spain[ J]. Vaccine, 2021, 39(52): 7646-7654.Ivanova-Markova Y, González-Domínguez A, Hidalgo A, et al. Cost
of illness of invasive meningococcal disease caused by serogroup B
Neisseria meningitidis in Spain[ J]. Vaccine, 2021, 39(52): 7646-7654.
18、于保荣, 许晴, 刘卓, 等. 新发传染病经济负担的方法学研究[ J].
卫生经济研究, 2017, (7): 25-29.
Yu BR, Xu Q, Liu Z, et al. Methodological study on economic burden
of emerging infectious diseases[ J]. Health Econ Res, 2017, (7): 25-29.于保荣, 许晴, 刘卓, 等. 新发传染病经济负担的方法学研究[ J].
卫生经济研究, 2017, (7): 25-29.
Yu BR, Xu Q, Liu Z, et al. Methodological study on economic burden
of emerging infectious diseases[ J]. Health Econ Res, 2017, (7): 25-29.
19、Cortaredona S, Ventelou B. The extra cost of comorbidity: multiple
illnesses and the economic burden of non-communicable diseases[ J].
BMC Med, 2017, 15(1): 216.Cortaredona S, Ventelou B. The extra cost of comorbidity: multiple
illnesses and the economic burden of non-communicable diseases[ J].
BMC Med, 2017, 15(1): 216.
20、田鑫, 郭秀花, 陈黎黎, 等. 初高中学生近视经济负担及其影响因
素研究[ J]. 卫生软科学, 2022, 36(10): 91-96.
Tian X, Guo XH, Chen LL, et al. Study on the economic burden
of myopia and its influencing factors in middle and high school
students[ J]. Soft Sci Health, 2022, 36(10): 91-96.田鑫, 郭秀花, 陈黎黎, 等. 初高中学生近视经济负担及其影响因
素研究[ J]. 卫生软科学, 2022, 36(10): 91-96.
Tian X, Guo XH, Chen LL, et al. Study on the economic burden
of myopia and its influencing factors in middle and high school
students[ J]. Soft Sci Health, 2022, 36(10): 91-96.
21、Ang M, Flanagan JL, Wong CW, et al. Review: Myopia control
strategies recommendations from the 2018 WHO/IAPB/BHVI
Meeting on Myopia[ J]. Br J Ophthalmol, 2020, 104(11): 1482-1487.Ang M, Flanagan JL, Wong CW, et al. Review: Myopia control
strategies recommendations from the 2018 WHO/IAPB/BHVI
Meeting on Myopia[ J]. Br J Ophthalmol, 2020, 104(11): 1482-1487.
22、Modjtahedi BS, Abbott RL, Fong DS, et al. Reducing the global burden
of myopia by delaying the onset of myopia and reducing myopic
progression in children: the academy 's task force on myopia[ J].
Ophthalmology, 2021, 128(6): 816-826.Modjtahedi BS, Abbott RL, Fong DS, et al. Reducing the global burden
of myopia by delaying the onset of myopia and reducing myopic
progression in children: the academy 's task force on myopia[ J].
Ophthalmology, 2021, 128(6): 816-826.
23、Chuvarayan%20Y%2C%20Finger%20RP%2C%20K%C3%B6berlein-Neu%20J.%20Economic%20burden%20%0Aof%20blindness%20and%20visual%20impairment%20in%20Germany%20from%20a%20societal%20%0Aperspective%3A%20a%20cost-of-illness%20study%5B%20J%5D.%20Eur%20J%20Health%20Econ%2C%202020%2C%2021(1)%3A%20%0A115-127.Chuvarayan%20Y%2C%20Finger%20RP%2C%20K%C3%B6berlein-Neu%20J.%20Economic%20burden%20%0Aof%20blindness%20and%20visual%20impairment%20in%20Germany%20from%20a%20societal%20%0Aperspective%3A%20a%20cost-of-illness%20study%5B%20J%5D.%20Eur%20J%20Health%20Econ%2C%202020%2C%2021(1)%3A%20%0A115-127.
24、龚慧, 申鑫, 严涵,等. 2006-2019年中国季节性流感疾病负担估计
[ J]. 中华医学杂志, 2021, 101(8): 560-567.龚慧, 申鑫, 严涵,等. 2006-2019年中国季节性流感疾病负担估计
[ J]. 中华医学杂志, 2021, 101(8): 560-567.
25、Koopmanschap MA, Rutten FF, van Ineveld BM, et al. The friction cost
method for measuring indirect costs of disease[ J]. J Health Econ, 1995,
14(2): 171-189.Koopmanschap MA, Rutten FF, van Ineveld BM, et al. The friction cost
method for measuring indirect costs of disease[ J]. J Health Econ, 1995,
14(2): 171-189.
26、Hanly P, Mag uire R , Dr ummond F, et al . Var iat ion in the
methodological approach to productivity cost valuation: the case of
prostate cancer[ J]. Eur J Health Econ, 2019, 20(9): 1399-1408.Hanly P, Mag uire R , Dr ummond F, et al . Var iat ion in the
methodological approach to productivity cost valuation: the case of
prostate cancer[ J]. Eur J Health Econ, 2019, 20(9): 1399-1408.
27、Sankaridurg P, Tahhan N, Kandel H, et al. IMI impact of myopia[ J].
Invest Ophthalmol Vis Sci, 2021, 62(5): 2.Sankaridurg P, Tahhan N, Kandel H, et al. IMI impact of myopia[ J].
Invest Ophthalmol Vis Sci, 2021, 62(5): 2.
28、Malhotra S, Kalaivani M, Rath R, et al. Use of spectacles for distance
vision: coverage, unmet needs and barriers in a rural area of North India[ J]. BMC Ophthalmol, 2019, 19(1): 252Malhotra S, Kalaivani M, Rath R, et al. Use of spectacles for distance
vision: coverage, unmet needs and barriers in a rural area of North India[ J]. BMC Ophthalmol, 2019, 19(1): 252
29、Islam MN, Rabbani A, Sarker M. Health shock and preference
instability: assessing health-state dependency of willingness-to-pay for
corrective eyeglasses[ J]. Health Econ Rev, 2019, 9(1): 32.Islam MN, Rabbani A, Sarker M. Health shock and preference
instability: assessing health-state dependency of willingness-to-pay for
corrective eyeglasses[ J]. Health Econ Rev, 2019, 9(1): 32.
30、Berdeaux G, Alió JL, Martinez JM, et al. Socioeconomic aspects of
laser in situ keratomileusis, eyeglasses, and contact lenses in mild to
moderate myopia[ J]. J Cataract Refract Surg, 2002, 28(11): 1914-
1923.Berdeaux G, Alió JL, Martinez JM, et al. Socioeconomic aspects of
laser in situ keratomileusis, eyeglasses, and contact lenses in mild to
moderate myopia[ J]. J Cataract Refract Surg, 2002, 28(11): 1914-
1923.
31、Vitale S, Cotch MF, Sperduto R, et al. Costs of refractive correction
of distance vision impairment in the United States, 1999-2002[ J].
Ophthalmology, 2006, 113(12): 2163-2170.Vitale S, Cotch MF, Sperduto R, et al. Costs of refractive correction
of distance vision impairment in the United States, 1999-2002[ J].
Ophthalmology, 2006, 113(12): 2163-2170.
32、Griffiths UK, Bozzani F, Muleya L, et al. Costs of eye care services:
prospective study from a faith-based hospital in Zambia[ J]. Ophthalmic
Epidemiol, 2015, 22(1): 43-51.Griffiths UK, Bozzani F, Muleya L, et al. Costs of eye care services:
prospective study from a faith-based hospital in Zambia[ J]. Ophthalmic
Epidemiol, 2015, 22(1): 43-51.
33、Balgos%20MJTD%2C%20Pi%C3%B1ero%20DP%2C%20Canto-Cerdan%20M%2C%20et%20al.%20Comparison%20of%20the%20%0Acost-effectiveness%20of%20SMILE%2C%20FS-LASIK%2C%20and%20PRK%20for%20myopia%20in%20a%20%0Aprivate%20eye%20center%20in%20Spain%5B%20J%5D.%20J%20Refract%20Surg%2C%202022%2C%2038(1)%3A%2021-26.Balgos%20MJTD%2C%20Pi%C3%B1ero%20DP%2C%20Canto-Cerdan%20M%2C%20et%20al.%20Comparison%20of%20the%20%0Acost-effectiveness%20of%20SMILE%2C%20FS-LASIK%2C%20and%20PRK%20for%20myopia%20in%20a%20%0Aprivate%20eye%20center%20in%20Spain%5B%20J%5D.%20J%20Refract%20Surg%2C%202022%2C%2038(1)%3A%2021-26.
34、Rein DB, Zhang P, Wirth KE, et al. The economic burden of major
adult visual disorders in the United States[ J]. Arch Ophthalmol, 2006,
124(12): 1754-1760.Rein DB, Zhang P, Wirth KE, et al. The economic burden of major
adult visual disorders in the United States[ J]. Arch Ophthalmol, 2006,
124(12): 1754-1760.
35、景冠达, 刘雨薇, 胡艳杰, 等. 加速康复外科在肝细胞癌肝切除术
患者中的应用效果与费用分析[ J]. 中国普外基础与临床杂志,
2021, 28(11): 1434-1438.
Jing GD, Liu YW, Hu YJ, et al. Effectiveness and cost analysis of
enhanced recovery after surgery in patients underwent radical resection
of hepatocellular carcinoma[ J]. Chin J Bases Clin Gen Surg, 2021,
28(11): 1434-1438.景冠达, 刘雨薇, 胡艳杰, 等. 加速康复外科在肝细胞癌肝切除术
患者中的应用效果与费用分析[ J]. 中国普外基础与临床杂志,
2021, 28(11): 1434-1438.
Jing GD, Liu YW, Hu YJ, et al. Effectiveness and cost analysis of
enhanced recovery after surgery in patients underwent radical resection
of hepatocellular carcinoma[ J]. Chin J Bases Clin Gen Surg, 2021,
28(11): 1434-1438.
36、杨怡芳. 云南省昆明及大理地区近视疾病经济负担研究[D] :昆
明医科大学,2018.
Yang YF. Economic burden of myopia in Kunming and Dali of Yunnan
Province[D].Kunming: Kunming Medical University, 2018.杨怡芳. 云南省昆明及大理地区近视疾病经济负担研究[D] :昆
明医科大学,2018.
Yang YF. Economic burden of myopia in Kunming and Dali of Yunnan
Province[D].Kunming: Kunming Medical University, 2018.
37、Lamparter J, Dick HB, Krummenauer F. Clinical benefit, complication
patterns and cost effectiveness of laser in situ keratomileusis (LASIK)
in moderate myopia: results of independent meta analyses on clinical
outcome and postoperative complication profiles[ J]. Eur J Med Res,
2005, 10(9): 402-409.Lamparter J, Dick HB, Krummenauer F. Clinical benefit, complication
patterns and cost effectiveness of laser in situ keratomileusis (LASIK)
in moderate myopia: results of independent meta analyses on clinical
outcome and postoperative complication profiles[ J]. Eur J Med Res,
2005, 10(9): 402-409.
38、Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions
for myopia control in children: a network meta-analysis[ J].
Ophthalmology, 2016, 123(4): 697-708Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions
for myopia control in children: a network meta-analysis[ J].
Ophthalmology, 2016, 123(4): 697-708
39、Xu T, Wang B, Liu H, et al. Prevalence and causes of vision loss in China
from 1990 to 2019: findings from the Global Burden of Disease Study
2019[ J]. Lancet Public Health, 2020, 5(12): e682-e691.Xu T, Wang B, Liu H, et al. Prevalence and causes of vision loss in China
from 1990 to 2019: findings from the Global Burden of Disease Study
2019[ J]. Lancet Public Health, 2020, 5(12): e682-e691.
40、Jan C, Xu R, Luo D, et al. Association of visual impairment with
economic development among Chinese schoolchildren[ J]. JAMA
Pediatr, 2019, 173(7): e190914.Jan C, Xu R, Luo D, et al. Association of visual impairment with
economic development among Chinese schoolchildren[ J]. JAMA
Pediatr, 2019, 173(7): e190914.
41、周籽秀, 徐珊珊, 易省平. 角膜塑形镜矫治青少年近视散光的
疗效及对角膜内皮细胞的影响[ J]. 国际眼科杂志, 2016, 16(8):
1525-1527.
Zhou ZX, Xu SS, Yi (S/X)P. Clinical effect of orthokeratology for
juvenile with myopia astigmatism and its effects on corneal endothelial
cells[ J]. Int Eye Sci, 2016, 16(8): 1525-1527.周籽秀, 徐珊珊, 易省平. 角膜塑形镜矫治青少年近视散光的
疗效及对角膜内皮细胞的影响[ J]. 国际眼科杂志, 2016, 16(8):
1525-1527.
Zhou ZX, Xu SS, Yi (S/X)P. Clinical effect of orthokeratology for
juvenile with myopia astigmatism and its effects on corneal endothelial
cells[ J]. Int Eye Sci, 2016, 16(8): 1525-1527.
42、陈彦, 潘建, 陈浙一, 等. 框架眼镜与角膜塑形镜治疗青少年近视
性屈光参差患者疗效比较[ J]. 国际眼科杂志, 2022, 22(4): 690-
692.
Chen Y, Pan J, Chen ZY, et al. Comparison of the efficacy in
adolescents with myopic anisometropia corrected by spectacles versus
orthokeratology[ J]. Int Eye Sci, 2022, 22(4): 690-692.陈彦, 潘建, 陈浙一, 等. 框架眼镜与角膜塑形镜治疗青少年近视
性屈光参差患者疗效比较[ J]. 国际眼科杂志, 2022, 22(4): 690-
692.
Chen Y, Pan J, Chen ZY, et al. Comparison of the efficacy in
adolescents with myopic anisometropia corrected by spectacles versus
orthokeratology[ J]. Int Eye Sci, 2022, 22(4): 690-692.
43、Dong L, Kang YK, Li Y, et al. Prevalence and time trends of myopia
in children and adolescents in China: a systemic review and meta-analysis[ J]. Retina, 2020, 40(3): 399-411.Dong L, Kang YK, Li Y, et al. Prevalence and time trends of myopia
in children and adolescents in China: a systemic review and meta-analysis[ J]. Retina, 2020, 40(3): 399-411.
44、Smith TST, Frick KD, Holden BA, et al. Potential lost productivity
resulting from the global burden of uncorrected refractive error[ J]. Bull
World Health Organ, 2009, 87(6): 431-437.Smith TST, Frick KD, Holden BA, et al. Potential lost productivity
resulting from the global burden of uncorrected refractive error[ J]. Bull
World Health Organ, 2009, 87(6): 431-437.
